2006
DOI: 10.1007/s11262-005-5843-2
|View full text |Cite
|
Sign up to set email alerts
|

Genomic Features of Attenuated Junín Virus Vaccine Strain Candidate

Abstract: Junin virus strain Candid #1 was developed as a live attenuated vaccine for Argentine haemorrhagic fever. In this paper, we report the nucleotide sequences of L RNA of Candid #1 and examine the relationship to its more virulent ancestors Junin virus XJ#44 and XJ 13 (prototype) and other closely and distantly related arenaviruses. Comparisons of the nucleotide and amino acid sequences of L and Z genes of Candid #1 and its progenitor strains revealed twelve point mutations in the L polypeptide that are unique to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0
2

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 42 publications
(40 citation statements)
references
References 18 publications
0
38
0
2
Order By: Relevance
“…Thus, it appears that Candid 1 did not adapt to using the mouse TfR1 for entry during the attenuation process, where there was selection for infection of mice. This attenuation resulted in four amino acid changes at the carboxyl terminus of GP1 and two more are at the carboxyl terminus of GP2, as well as 6 additional nonsynonymous changes in the L protein (24,25). In our studies, Candid 1 infected mouse cells by a TfR1-independent mechanism while maintaining its requirement for TfR1 on human cells (Fig.…”
Section: Discussionmentioning
confidence: 66%
See 1 more Smart Citation
“…Thus, it appears that Candid 1 did not adapt to using the mouse TfR1 for entry during the attenuation process, where there was selection for infection of mice. This attenuation resulted in four amino acid changes at the carboxyl terminus of GP1 and two more are at the carboxyl terminus of GP2, as well as 6 additional nonsynonymous changes in the L protein (24,25). In our studies, Candid 1 infected mouse cells by a TfR1-independent mechanism while maintaining its requirement for TfR1 on human cells (Fig.…”
Section: Discussionmentioning
confidence: 66%
“…An attenuated vaccine strain of Junín virus, Candid 1, has been developed by extensive passaging through neonatal mouse brain, guinea pigs, and primate tissue culture cells (7). There are approximately 12 amino acid differences between different pathogenic JUNV primary isolates and Candid 1, 6 of which are located in the GP (24,26).…”
Section: At Least 5 Members Of the Arenavirus Family Cause Viral Hemomentioning
confidence: 99%
“…These passages are usually accompanied by the acquisition of several adaptive mutations in the viral genome, with one or a few of these mutations responsible for the attenuated phenotype that is desired in a vaccine strain (12,18,49). This cell culture virus-passaging procedure was utilized by Levitt et al to produce the 181/25 CHIKV vaccine strain to protect against CHIK (21), a debilitating illness that has affected millions of people during recent outbreaks (41).…”
Section: Discussionmentioning
confidence: 99%
“…The attenuated Candid#1 strain of JUNV (5,42) was provided by Robert Tesh (WHO Reference Center for Arboviruses) and was propagated in Vero cells. The Z protein cDNA from the Candid#1 virus (28) was kindly provided by Victor Romanowski (National University of La Plata, La Plata, Argentina) and was subsequently engineered to encode a C-terminal S peptide (Spep) tag (31,77). The GPC and Z proteins of MC2 and Candid#1 are essentially identical, each containing two conservative amino acid substitutions among 485 and 94 residues, respectively.…”
Section: Methodsmentioning
confidence: 99%